ATG16L1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.7759127501904E-12 |
Normal-vs-Stage2 |
2.04999999999789E-05 |
Normal-vs-Stage3 |
1.92280003030731E-09 |
Normal-vs-Stage4 |
1.71079999999879E-06 |
Stage1-vs-Stage2 |
8.198600E-01 |
Stage1-vs-Stage3 |
1.173390E-01 |
Stage1-vs-Stage4 |
2.193400E-01 |
Stage2-vs-Stage3 |
3.109600E-01 |
Stage2-vs-Stage4 |
2.953800E-01 |
Stage3-vs-Stage4 |
2.080100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62436730732907E-12 |
Normal-vs-AfricanAmerican |
8.23120000000843E-05 |
Normal-vs-Asian |
4.30690000000622E-05 |
Caucasian-vs-AfricanAmerican |
9.513600E-01 |
Caucasian-vs-Asian |
9.054600E-01 |
AfricanAmerican-vs-Asian |
9.272600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62458935193399E-12 |
Normal-vs-Female |
2.99040014972718E-10 |
Male-vs-Female |
5.217800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.698300E-02 |
Normal-vs-Age(41-60Yrs) |
4.00790511889682E-14 |
Normal-vs-Age(61-80Yrs) |
5.78426195829707E-14 |
Normal-vs-Age(81-100Yrs) |
1.462180E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.404000E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.251630E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.857000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.671200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.858000E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.417100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
9.046300E-04 |
Normal-vs-Grade 2 |
3.00903746364156E-12 |
Normal-vs-Grade 3 |
1.91180404840452E-13 |
Normal-vs-Grade 4 |
4.07909999999845E-07 |
Grade 1-vs-Grade 2 |
7.138000E-02 |
Grade 1-vs-Grade 3 |
1.302360E-01 |
Grade 1-vs-Grade 4 |
2.905800E-01 |
Grade 2-vs-Grade 3 |
5.959200E-01 |
Grade 2-vs-Grade 4 |
4.065200E-01 |
Grade 3-vs-Grade 4 |
6.882400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.12360129481226E-11 |
Normal-vs-ccB subtype |
2.32036612146658E-14 |
ccA subtype-vs-ccB subtype |
9.459600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.68831615354748E-12 |
Normal-vs-N1 |
1.209720E-02 |
N0-vs-N1 |
6.188800E-01 |
|
|